衰弱老年人及预期寿命有限者的减药工具:系统综述
工具分为框架模型类(2种)、全药物列表减药方法类(9种)和药物特异性建议类(4种),但仅4种经过临床实践检验且研究质量极低。目前尚不清楚在实际中使用这些工具能否改善临床结局或减少不适当用药。
要点
- 15种减药工具分三类:框架模型2种、整体减药方法9种、药物特异性建议4种。
- 仅4种工具在临床实践中被检验,且相关研究质量极低。
- 多数工具基于专家意见,开发方法差异大且合成方法描述不清。
核心结论
- 已有工具可帮助临床医生在衰弱老年人及预期寿命有限者中实施减药,但其对临床结局或减少不适当用药的效果尚待研究。
主要发现
- 共识别15种工具,分为框架模型类(n=2)、全药物列表减药方法类(n=9)和药物特异性建议类(n=4)。
- 工具复杂度从简单列表到详细分步方案不等,开发方法差异大,合成方法普遍描述不清。
- 多数工具基于专家意见,仅4种在临床实践中被检验且研究质量极低。
关键数值与推荐
- 仅4/15种工具在临床实践中被检验,相关研究质量极低。
临床怎么用
- 临床医生可在减药过程的不同阶段参考这些工具,但需注意其证据基础薄弱且未经高质量实践验证。
局限性
- 工具开发方法差异大且合成方法描述不清,多数基于专家意见,仅少数经临床实践检验且研究质量极低。
- 尚不清楚使用这些工具能否改善临床结局或减少不适当用药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To summarize available tools that can assist clinicians in identifying and reducing or stopping (deprescribing) potentially inappropriate medications and that specifically consider frailty or limited life expectancy. DESIGN: Systematic review and narrative synthesis. SETTING: We searched MEDLINE (via Ovid SP), EMBASE (via Ovid SP), and CINAHL from inception to December 2017, along with grey literature. We included articles that described a tool to guide deprescribing of medications. PARTICIPANTS: Frail older persons and older persons with limited life expectancy. MEASUREMENTS: Narrative description of tools. RESULTS: We identified 15 tools and organized them into three main categories: tools (n = 2) that described a model or framework for approaching deprescribing, tools (n = 9) that outlined a deprescribing approach for the entire medication list, and tools (n = 4) that provided medication-specific advice. The complexity of the tools ranged from simple lists to detailed, step-wise protocols. The development methodology varied widely, and the methods used to synthesize the tools were generally not well described. Most tools were based on expert opinion. Only four of the 15 tools have been tested in clinical practice (in very low-quality studies). CONCLUSION: Tools exist to help clinicians deprescribe in frail older persons and those with limited life expectancy. These tools may assist clinicians at various stages in the deprescribing process. However, it remains to be investigated whether use of such tools in practice is likely to improve clinical outcomes or reduce inappropriate medication use. J Am Geriatr Soc 67:172-180, 2019.
引用
- Thompson W, Lundby C, Graabaek T, et al. Tools for Deprescribing in Frail Older Persons and Those with Limited Life Expectancy: A Systematic Review. J Am Geriatr Soc. 2018. PMID: 30315745. doi:10.1111/jgs.15616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。